Oncology
Ana Garrido-Castro, M.D.
Assistant Professor of Medicine; Director, Triple-Negative Breast Cancer Research, Division of Breast Oncology
Ana C. Garrido-Castro, MD, is a medical oncologist specializing in breast cancer at Dana-Farber Cancer Institute in Boston, Massachusetts, and Assistant Professor of Medicine at Harvard Medical School. She directs Triple-Negative Breast Cancer (TNBC) Research in the Division of Breast Oncology and co-directs the TNBC Working Group. Her clinical practice and research focus on developing novel therapies for breast cancer patients, with particular emphasis on triple-negative breast cancer. She lead
9+
Years in Practice
Credentials
Education & Training
- Dana-Farber Cancer Institute — Fellowship
- Hospital Universitario Vall d’Hebron, Barcelona, Spain — Residency
- Universidad Autónoma de Madrid, Madrid, Spain — M.D., Class of 2010
Peer Recognition
- Breast Cancer Alliance — Young Investigator Award
- Breast Cancer Research Foundation — Marion R. Wright Award for Scientific Excellence
- Conquer Cancer Foundation of ASCO – Triple Negative Breast Cancer Foundation — Advanced Clinical Research Award in Triple-Negative Breast Cancer Research
2023
- Susan G. Komen — Career Catalyst Research Grant
Clinical Focus
Subspecialties
Conditions & Treatments
Practice Details
Hospital Affiliations
- Dana-Farber Cancer Institute
- Susan F. Smith Center for Women’s Cancers
Languages
English, Spanish
Experience
9+ years in practice